Keywords: xoma, losses, widen, ahead, marketing, california, usa-based
Xoma's losses widen ahead of marketing
Article | 24 March 2003
California, USA-based biotechnology concern Xoma has reported a net lossof $33.2 million, or $0.47 per share, for 2002, compared with $28.0 million, or $0.41 per ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
